Key result
Obesity and visceral adiposity in polycystic ovary syndrome are associated with low-grade inflammation and raised inflammatory cytokines, linking fat distribution to adipocyte dysfunction.
This review highlights the link between visceral adiposity, low-grade inflammation, and increased cardiovascular risk in women with PCOS.
Answers are grounded in this paper and cite their sources.
Highlights potential CV risk via inflammation in obese PCOS; leaves open causal pathways and therapeutic targets.
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group and is associated with a higher cardiovascular risk. Obesity, mainly visceral adiposity, is prevalent in patients with PCOS. Obesity is associated with low-grade inflammation and raised inflammatory cytokines, both of which are also described in patients with PCOS. In this paper, the potential relationships between fat distribution, adipocyte dysfunction and, altered inflammatory markers in patients with PCOS have been discussed.
No takes yet. Share an insight, caveat, or question.
Sathyapalan et al. (2010) conducted a review in Polycystic ovary syndrome (PCOS). Obesity and visceral adiposity was evaluated. Obesity and visceral adiposity in polycystic ovary syndrome are associated with low-grade inflammation and raised inflammatory cytokines, linking fat distribution to adipocyte dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: